PANCREATIC CANCER, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
1
|
14
|
0.400 |
None |
1.000 |
2 |
14
|
2007 |
2007 |
Bilateral Malignant Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Ureter duplex
|
disease |
|
Congenital Abnormality
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Stage IA Breast Cancer AJCC v7
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Anatomic Stage IA Breast Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Prognostic Stage IA Breast Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
stage IA breast cancer
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Congenital atresia of colon
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases
|
Congenital Abnormality
|
2
|
3
|
0.100 |
None |
|
0 |
1
|
|
|
Anal canal squamous cell carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Bilateral Carcinoma
|
phenotype |
Neoplasms
|
Neoplastic Process
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Neuroendocrine tumor of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2
|
2
|
0.100 |
None |
|
0 |
1
|
|
|
FANCONI ANEMIA, COMPLEMENTATION GROUP N
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
4
|
13
|
0.710 |
definitive |
1.000 |
6 |
13
|
2007 |
2018 |
increased risk of pancreatic cancer
|
phenotype |
Neoplasms
|
Finding
|
5
|
6
|
0.100 |
None |
|
0 |
1
|
|
|
Unilateral Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
7
|
2
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Unilateral Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
7
|
2
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hereditary Diffuse Gastric Adenocarcinoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
8
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Abnormality of limbs
|
phenotype |
|
Anatomical Abnormality
|
8
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Functional intestinal obstruction
|
phenotype |
Digestive System Diseases
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Chromosomal breakage induced by crosslinking agents
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Abscess of peritoneum
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Infections
|
Disease or Syndrome
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
Carcinoma of peritoneum
|
disease |
|
Neoplastic Process
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Limb joint contracture
|
phenotype |
|
Finding
|
10
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
BREAST CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
24
|
0.100 |
None |
|
0 |
8
|
|
|
Anatomic Stage IV Breast Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Prognostic Stage IV Breast Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |